Concepedia
Statistics
Publications
13
Citations
455
H-Index
11
Active since
2002
Affiliations
Harvard University(Current)
Tetraphase Pharmaceuticals (United States)
Harvard University Press
Philip C. Hogan is an author at Harvard University specializing in medicinal chemistry, drug discovery, and chemistry.
Publications per year
2002–2017
Proteasome Inhibition by a Totally Synthetic β-Lactam Related to Salinosporamide A and Omuralide
Philip C. Hogan, E. J. Corey · Journal of the American Chemical Society · 2005 · 74 citations
Life Sciences, Biochemistry, Medicinal Chemistry +11
Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
Roger B. Clark, Diana K. Hunt, Minsheng He et al. · Journal of Medicinal Chemistry · 2011 · 72 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
Kedarcidin Chromophore: Synthesis of Its Proposed Structure and Evidence for a Stereochemical Revision
Feng Ren, Philip C. Hogan, Alan J. Anderson et al. · Journal of the American Chemical Society · 2007 · 71 citations
Natural Sciences, Biochemistry, Chemistry +13
Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development
Magnus Rönn, Zhijian Zhu, Philip C. Hogan et al. · Organic Process Research & Development · 2013 · 59 citations
Pharmacy, Chemistry, Medicinal Chemistry +11
Enantioselective Synthesis of Kedarcidin Chromophore Aglycon in Differentially Protected Form
Andrew G. Myers, Philip C. Hogan, Alexander R. Hurd et al. · Angewandte Chemie International Edition · 2002 · 52 citations
Pharmacy, Chemistry, Medicinal Chemistry +16
1–5 of 13